Stay updated with breaking news from Denisem Bohnert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amedisys, Inc. (NASDAQ:AMED – Get Rating) – Oppenheimer lowered their FY2022 earnings per share estimates for Amedisys in a research report issued on Thursday, September 15th. Oppenheimer analyst M. Wiederhorn now expects that the health services provider will post earnings per share of $5.34 for the year, down from their prior estimate of $5.42. The […]
Bank of New York Mellon Corp boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 30.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 578,616 shares of the health services provider’s stock after acquiring an additional […]
Crossmark Global Holdings Inc. decreased its stake in Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 4.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,789 shares of the health services provider’s stock after selling 130 shares during the period. […]
Comerica Bank increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 2.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,500 shares of the health services provider’s stock after buying an additional 345 shares during […]